The investment model of "the introduction of innovative technology into cross-border capital investment" has won high praise from governments all over China!
Infinity Equity Management Co., Ltd. (Infinity Capital) is the core business body in Greater China of Infinity Group, a leading investment management company from Israel, which mainly operates domestic RMB fund and cross-border M&A business. Infinity Capital bases in 12 cities of China, forming five major business areas such as North China, East China, South China, Southwest, Hong Kong and overseas. With the advantage of resources in Israel, we insist on the introduction of cross-border capital investment in innovation technology, and we are committed to building important ties and bridges of cooperation in science, technology and innovation between China and Israel. At present, the investment fund size of Infinity in China is nearly 5 billion RMB, in TMT (science and technology, media, communications), health and life sciences, energy conservation and environmental protection, precision manufacturing and new materials and other areas of the key layout, has been invested in 80 deals. In the last two years alone, Infinity Capital have been four successful listings of Vincent Medical (HK01612), AsymChem (002821), Huati Technology (603679), Liancheng Precision (002921). Golden Point Gardens, Hongtu Separator, IOPtima has been acquired by Meishang Ecology (300495). Jinguan Electrical (300510), Kanghong Pharmaceutical (002773) respectively which achieved good results. At present, a number of portfolio companies are preparing to IPO. Infinity Capital maintains close cooperation with well-known outstanding venture capital companies and listed companies, adhering to the prudent and professional investment philosophy, constantly helping the investment companies to continue to grow up, creating long-term and generous returns for shareholders and partners under low risk.